Immunoprecipitation of H-2K b molecules from normal cells showed that 28.8.6 and 34.4.20 epitopes were only present on a subset of all conformationally reactive H-2K b molecules. Using alanine-substituted derivatives of the VSV peptide, the 28.8.6 epitope was completely stabilized by substitution of the first residue and partially stabilized by substitution of the third or the fifth residues in the peptides. These results indicate that distinct conformational MHC epitopes are dependent on the specific peptide that occupies the antigenic peptide binding groove on individual MHC molecules. The changes in MHC epitopes observed may also be important in understanding the diversity of T cell receptors used in an immune response and the influence of peptides on development of the T cell repertoire.
C
lass I MHC molecules are polymorphic cell surface antigens with central roles in T cell-mediated immune responses (for review see reference 1). Stable class I MHC expression requires three components, a 45-kD polymorphic H chain, a nonpolymorphic L chain (fl2-microglobulin), and a peptide bound to the antigenic peptide binding groove in the H chain. Currently, evidence indicates that nascent class I MHC molecules associate with 32-microglobulin (2-4) and antigenic peptide fragments (5-7) in the endoplasmic reticulum (ER) 1. This association is required for stable cell surface expression. By studying cells that have global defects in class I MHC expression, such as the routine RMA-S and the human B cell line .174 (8, 9) , investigators have identified novel genes involved in antigen processing that regulate cell surface expression of class I MHC molecules (10) (11) (12) (13) (14) . Under normal culture conditions these cells do not properly process antigen and fail to load their endogenous nascent class I MHC molecules with antigenic peptide fragments. Because of this 1 Abbreviations used in this paper: ER, endoplasmic reticulum; MCMV, murine cytomegalovirus; NP, nudeoprotein; VSV, vesicular stomatic virus. defect, these cells do not express normal levels of cell surface MHC class I molecules. However, "empty" MHC molecules are expressed on the surface of RMA-S cells when these cells are cultured between 20 and 28~ (15) . Although these molecules are stable at lower temperatures, they rapidly disassociate or degrade at 37~ Empty class I MHC molecules can be stabilized by the addition of antigenic peptides (15) or anti-class I MHC antibodies (16) .
In the present investigation, we found that serologically distinct conformational epitopes on the class I MHC H-2K b molecule were stabilized by loading these cells with different H-2K b binding peptides. Although many determinants recognized by mAbs specific for H-2K b molecules were reactive regardless of which antigenic peptide bound to H-2K b, two oe2-specific epitopes recognized by mAbs 28.8.6 and 34.4.20 were dependent on the specific peptide bound to H-2K b. An analysis of the oL2 epitope recognized by mAb 28.8.6 indicates that specific amino acid residues at positions 1, 3, and 5 in the H-2K b binding peptide control stabilization of that epitope. These results indicate that distinct H-2K b binding antigentic peptides stabilize different conformational epitopes on H-2K b. Changes in conformational MHC epitopes, as detected serologically, may also be important in TCR recognition of a particular MHC molecule and may partially explain the diversity of TCRs used in responding to specific MHC antigens. raAbs, mAbs were either used as culture supernatants or further purified by protein A-Sepharose chromatography. See Table  1 for specificity of different mAbs used to recognize either or1 or c~2 serological epitopes.
Peptide Loading of Cells. Cells (RMA, RMA-S, or E3 K b) were incubated at either 25~ overnight or at 37~ for peptide-loading experiments. Ceils that were maintained at 37~ were either incubated overnight in the presence of various antigenic peptides (100 #M final concentration) or in the absence of any known antigenic peptides. The following morning cells were harvested and processed for flow microftuorometry analysis. Ceils that were maintained overnight at 25~ were incubated with antigenic peptides (100/~M) in the morning for 2 h and then incubated for an additional 2 h at 37~ CeUs were then harvested and processed for flow microfluorometry analysis as described. All peptides except murine cytomegalovirus (MCMV) pp89 were made by the Johns Hopkins University biopolymer laboratory peptide synthesis facility. Peptides were made by F-moc chemical synthesis and then purified by preparative HPLC. Sequences were confirmed by amino acid analysis and protein sequencing. The MCMV pp89 peptide was the generous gift of Dr. David Margulies (National Institutes of Health).
Imraunoprecipitation. For labeling of cells, 108 cells were incubated at 37~ for 40 min in 2 ml methionine-free RPMI-1640 supplemented with 5% dialyzed FCS.
[3sS]Methionine (0.5 mCi) was added for 15 min. Labeling was stopped by the addition of 2 mM cold methionine at 37~ After incubation for an additional 2 h, the cells were harvested and 20 ml ice-cold PBS was added. The ceUs in PBS were centrifuged at 4~ and the pellet lysed in I ml lysis buffer (0.5% NP-40, 20 mM Tris, pH 8.0, 10 mM EDTA, pH 8.0, 0.1 M NaC1, and 1 mM PMSF). After 30 rain on ice, the nuclei were sedimented at 14,000 rpm for 5 min at 4~ Ly- 
Results
Culturing RMA-S cells at 25~ overnight is known to enhance expression of empty class I MHC molecules (15) . In our system, flow microfluorometric analysis of cells cultured at 25~ showed 2.5-3.5-fold increases in expression of conformationally intact H-2K b molecules (Fig. 1) . These empty H-2K b molecules were reactive with the entire set of two oil-reactive anti-H-2K b specific mAbs, 20.8.4 and B8.24.3, and four oe2-reactive anti-H-2K b specific mAbs, 5F1, 28.8.6, 34.4.20, and Y-3 (data not shown for Yo3).
To study epitopes expressed on peptide-stabilized class I MHC molecules, we analyzed the ability of four H-2K b binding peptides to stabilize empty H-2K b molecules expressed on RMA-S cells ( Table 2 ). Three of the peptides used were previously reported to bind to H-2K b, vesicular stomatic virus nucteoprotein (VSV NP) (52-59), OVA (257-264), and influenza NP (Y345-360). The fourth peptide, MCMV pp89 (168-176) that was previously described as an H-2L a binding peptide, also bound to empty cell surface H-2K b molecules (Fig. 2 ). H-2K b binding was analyzed by adding peptides to RMA-S cells that had been cultured overnight at 25~ After allowing the peptide to bind and stabilize the cell surface MHC molecules at 250C, cells were cultured for an additional 2 h at 37~ to degrade any remaining empty H-2K b molecules. Compared to cells treated with either a control peptide, influenza NP (365-380), or no pep- influenza NP (Y345-360) did not stabilize the epitope recognized by mAb 34.4.20 ( Fig. 2 B) . The VSV (52-59) peptide increased 34.4.20 reactivity 2.5-fold. Other oe2-specific epitopes on H-2K b were not dependent on the specific H-2K b binding peptide resident in the H-2K b molecule (Fig. 2) (Fig. 4) . Two rounds of immunoprecipitation depleted the 28.8.6-reactive material from the cell lysates (Fig. 4 A, lanes A-C) . Even after three rounds of immunoprecipitation of the 28.8.6-reactive material, significant amounts of 20.8.4-reactive H-2K b remained in the lysates (Fig. 4 A, lane D) . Whereas significantly less material was immunoprecipitated by mAb 34.4.20 ( It has previously been shown that MHC determinants expressed on erythrocytes and blastocysts are serologically distinct from the same MHC determinants expressed on lymphocytes (21) . In retrospect, this may reflect a different spectrum of peptide-specific MHC determinants expressed by blastocysts and by erythrocytes than those found on lymphocytes that were used to make the mAbs. It is interesting that it was also the cr epitopes that were missing from the MHC molecules expressed by the erythrocytes.
A likely explanation of our data is that dass I MHC molecule conformations are peptide dependent. Empty MHC molecules, which are reactive with all mAbs tested, are conformationaUy unstable. Presumably, these empty molecules exist in a temperature-dependent floppy configuration. In this case, MHC molecules can explore conformational states and can be trapped in a specific conformational state by mAbs (16) . The recent three-dimensional x-ray crystallography structure of H-2K b cocrystallized with two different peptides shows that small but significant differences in the H-2K b class I MHC molecule were seen when crystallized with the two different peptides (22) . Our results indicate that when antigenic peptides bind to either empty cell surface MHC molecules or newly formed MHC molecules in the ER, the peptide may also fix the MHC molecule in one of several serologically distinct configurations. Our strongest support for this hypothesis is from the effects of alanine substitution at position 5 in the VSV peptide on stabilization of the epitope recognized by 28.8.6. Both positions 3 and 5 are anchor residues that interact directly with amino acid residues in the MHC molecule. Position 5 in the VSV peptide is a buried residue whose side chain faces down and is not exposed to solvent (22) . It is unlikely that position 5 in the VSV peptide can directly interact with the surface of the MHC molecule. Thus the influence of position 5 and in the VSV peptide on 28.8.6 reactivity is probably not secondary to steric interactions between that position in the peptide and the mAb. These changes may be indicative of conformational changes in the MHC molecule.
Although we favor the hypothesis that the differences seen in the serological reactivity with different H-2K b binding peptides indicates a conformational change in the MHC molecule, there are other interpretations of the data. An alternative hypothesis is that individual antigenic peptides, when bound to MHC molecules, can obscure specific mAb reactivities. The strongest argument for this idea is from the finding that all the serological epitopes are expressed on conformationally unstable empty H-2K b molecules. Thus one might argue that when the antigenic peptide derived from VSV NP (52-59) bound to the H-2K b molecule, it obscured the epitope recognized by 28.8.6 but not the epitope seen by 34.4.20. The three-dimensional x-ray crystallographic data indicate that the nonamer peptide is embedded in the antigenic peptide binding groove and that the peptide backbone is thought to lie deep in the antigenic peptide binding groove (23, 24) . Thus it seems unlikely that nonamer peptides could entirely mask serological epitopes that have been mapped to polymorphisms on the surface of the MHC helical regions (23) . However, peptide side chains could still interact with the surface of the MHC molecule (24) and interfere with access to mAb binding sites. The effect of an alanine for arginine substitution at position 1 of the VSV (52-59) peptide seen in analysis of the H-2K b epitope recognized by mAb 28.8.6 could be due to steric inhibition. This H-2K b epitope is known to map to the terminal portion of the c~ helix of the oe2 domain (17) . Alteration of amino acid positions 167 or 173 of H-2K b completely abolishes the 28.8.6 epitope on H-2K b (J. P. Schneck, unpublished data). Based on the crystal structure of antigenic peptides bound to MHC molecules, we know that the NH2-terminal portion of antigenic peptides lie in close proximity to the beginning of the oe helical region of or1 and the terminal portion of the ot helical region of or2. Thus arginine in position 1 could directly influence the relevant area of the MHC molecule and may sterically interfere with binding of mAb 28.8.6. Ultimately, a structural analysis of MHC molecules loaded with either one of two different peptides that have been shown to stabilize serologically distinct forms of that MHC molecule will help determine if the MHC is fixed in two different conformational states, or if peptides obscure different serological epitopes.
Another hypothesis we entertained was that these mAb binding sites were combinational binding sites that were part MHC and part peptide. This seems unlikely since all the mAbs react with the empty H-2K b molecule. Even if the empty MHC molecules are only functionally empty, it is still unlikely that the antibody binding sites are combinational. Were this the case, it is surprising that reactivity with mAb 28.8.6 could be stabilized by incubation with the two different peptides derived from either OVA (257-264) or from MCMV pp89. These peptides have no apparent homology to each other. Even the H-2K b peptide binding motif (25) is not easily identifiable in the MCMV peptide. Since peptides derived from VSV, MCMV, and OVA do not occur naturally in the mouse, it also seems unlikely that we would have stumbled on three peptides that were crossreactive with actual endogenously occurring peptides that could potentially form part of the binding cleft for the mAbs. If these antibodies actually have combinational binding sites, they are qualitatively different than other mAbs that have combinational binding sites (26) (27) (28) . These previously described mAbs with combinational binding sites are specific for a single peptide in the context of an MHC molecule. The unique aspect of the antibodies reported in this study is that they are not specific for one peptide, but recognize a class of peptides associated with H-2KL Independent of the mechanism by which peptides alter serological MHC epitopes, presumably, these changes are also important for TCR recognition. Whereas antigenic peptide binding to MHC molecules clearly confers a specific conformation that antigen-specific TCRs recognize, our data shows that a prominent effect of antigenic peptide binding is loss of certain serological conformational MHC epitopes. Recent work analyzing TCR interaction with the antigenic peptide-MHC complex has focused on the direct interaction between the third hypervariable region of the c~ and 3 chains of the TCRs and the antigenic peptide bound to the MHC molecule (29, 30) . However, this does not explain why T cells often use many different ot and 3 chains when interacting with a specific MHC restriction element. Different TCR c~ and 3 chains not only have changes in the third hypervariable domain, but also differ in the first two hypervariable regions. The loss of conformational epitopes seen with peptide binding may also influence contact regions between the first two hypervariable regions on the ot and B chains of the TCR and the MHC portion of the antigen-MHC complex. Thus a TCR may use different ot and ~ chains to accommodate specific antigenic peptide-MHC complexes that have either stabilized the MHC in a specific conformation or limited access to certain area of the MHC molecule. Peptide-dependent alterations in the MHC molecule may also influence the way endogenous peptides in the thymus shape the development of the T cell repertoire during thymic maturation.
The experimental system described here uses cells that express empty MHC molecules to probe the influence of specific peptides on MHC structure. This system has allowed us to analyze the effects of uniform loading of MHC molecules with specific peptides on the conformational states of MHC molecules. These findings indicate that peptide binding to MHC molecules may affect the T cell repertoire by topographically altering the areas available for interaction between MHC molecules and TCRs.
